PRLog - Jan. 10, 2013 - MORRIS PLAINS, N.J. -- Commercialization of Pharmaceutical Products in the USA – A Practical Guide (2nd Edition)
Morris Plains, New Jersey—RxCommercial Research International has announced the release of the second edition of its successful Practical Guide on commercializing pharmaceutical products in the USA. Pharmaceutical and Biotechnology companies produce innovative life-saving and life-enhancing medicines for patients. The discovery, development, manufacturing, distribution, and commercialization of a biopharmaceutical product are highly complex processes and they get further compounded due to the regulatory nature of the industry. This book not only offers insights into all areas of the product value chain but also shows strategic choices that companies have to deal with at each and every stage of the commercialization process.
In the current US value-driven healthcare environment, product commercialization requires developing a compelling outcomes-driven value story and selling it to diverse stakeholder groups such as patients, providers, payers, and policy makers to ensure product adoption. The commercial success of a product is critical in maximizing a product’s potential and as well as the shareholder return.
According to RxCommercial’
About RxCommercial Research International Inc.
RxCommercial Research International offers “innovative and practical insights into investing and commercializing life sciences products.” The firm publishes Practical Guides to empower investors and professionals in the pharmaceutical, biotechnology, medical devices and diagnostics sectors. The company has a global presence with the headquarters in New Jersey, USA. RxCommercial publications (paperback and eBooks) could be purchased online athttp://www.rxcommercial.com/
RxCommercial Research International Inc.
Morris Plains, New Jersey 07950
Source: RxCommercial Research International Inc.